
Trump does not pick cabinet officials based on their merits. He picks cabinet officials based on their -- whether they're willing to be his flunky and Barr is a flunky.
On the public record
Every politician on the site, every statement on file. Search, filter, and read the public record.
20,100+·quotes on file

Trump does not pick cabinet officials based on their merits. He picks cabinet officials based on their -- whether they're willing to be his flunky and Barr is a flunky.

Those are her words and I couldn't agree more than any effort to fulfill the promise of Brown has to include a commitment to parent empowerment.

He did hit the 10,000 lie mark today which is pretty extraordinary after two and a half years in the office.

It is clear we have a lot of work to do at every level of educational governance to ensure the promise of Brown is fulfilled for every child.

I may be the only person sitting up here that graduated from high school in the segregated school system in the rural South.

I don't see how you can ask a parent in a failing school to keep their--that is the only chance that child has.

If we just have these costs go out of control, continue to go out of control, that cuts off access.

I would just urge us to try to look for some way where we address this patient choice issue, because I know a lot of my colleagues have that concern. I have that concern.

I'm amazed. I'm coming home, and they're there delivering the mail. They've been at it for 10 or 12 hours.

I look forward to hearing from our witnesses, or our witness, on whether the current structure of how Part B drugs are reimbursed--can and should be modified to foster competition and to lower prices.

One consistent concern I hear about from my constituents in Oregon, and I have done 20 town halls so far this year, is the high cost of prescription drugs.

we are the only Government that I am aware of that really doesn't play an active role in trying to provide some pricing protection to benefit our taxpayers and consumers.

There is some argument that is always made by the pharma companies that if there is some pushback on their pricing power, that somehow means they are not going to innovate. I find that to be bogus because they are spending more on…